Flowers Foods Inc FLO
2 targets with a reported result
Releases of the last 3 yearsThe numbers FLO said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $465.00M to $495.00M release Feb 12, 2026
Kept $465.00M to $495.00M release May 21, 2026
Lowered $453.00M to $481.00M release Aug 20, 2026
Lowered $415.00M to $430.00M release Nov 12, 2026
|
– | No standard number | |
The company's wordsFor the 52-week Fiscal 2026, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $465 million to $495 million. release Feb 12, 2026 For the 52-week Fiscal 2026, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $465 million to $495 million. release May 21, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $453 million to $481 million, compared to prior guidance of $465 million to $495 million. release Aug 20, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $415 million to $430 million, compared to prior guidance of $453 million to $481 million. release Nov 12, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $0.80 to $0.90 release Feb 12, 2026
Kept $0.80 to $0.90 release May 21, 2026
Lowered $0.75 to $0.85 release Aug 20, 2026
Lowered $0.63 to $0.68 release Nov 12, 2026
|
– | No standard number | |
The company's wordsFor the 52-week Fiscal 2026, the Company Expects: … Adjusted diluted EPS (3) of approximately $0.80 to $0.90. release Feb 12, 2026 For the 52-week Fiscal 2026, the Company Expects: … Adjusted diluted EPS (2) of approximately $0.80 to $0.90. release May 21, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Adjusted diluted EPS (2) of approximately $0.75 to $0.85 per share, compared to prior guidance of $0.80 to $0.90 per share. release Aug 20, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Adjusted diluted EPS (2) of approximately $0.63 to $0.68 per share, compared to prior guidance of $0.75 to $0.85 per share. release Nov 12, 2026 | ||||
| Revenue Fiscal 2026 |
Given $5.16B to $5.27B release Feb 12, 2026
Kept $5.16B to $5.27B release May 21, 2026
Lowered $5.07B to $5.14B release Aug 20, 2026
Lowered $5.02B to $5.06B release Nov 12, 2026
|
– | Not reported yet | |
The company's wordsFor the 52-week Fiscal 2026, the Company Expects: … Net sales of approximately $5.163 billion to $5.267 billion, representing a -1.8% to 0.2% change compared to the prior year. release Feb 12, 2026 For the 52-week Fiscal 2026, the Company Expects: … Net sales of approximately $5.163 billion to $5.267 billion, representing a -1.8% to 0.2% change compared to the prior year. release May 21, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Net sales of approximately $5.070 billion to $5.142 billion, representing a -3.5% to -2.2% change compared to the prior year. release Aug 20, 2026 Revised Outlook: 52-week Fiscal 2026, the Company Expects: … Net sales of approximately $5.016 billion to $5.063 billion, representing a -4.6% to -3.7% change compared to the prior year. release Nov 12, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Jan 3, 2026) |
Given $560.00M to $591.00M release Feb 7, 2025
Lowered $534.00M to $562.00M release May 16, 2025
Lowered $512.00M to $538.00M release Aug 15, 2025
Lowered $515.00M to $532.00M release Nov 6, 2025
|
– | No standard number | |
The company's wordsFor the 53-week Fiscal 2025, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $560 million to $591 million. release Feb 7, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $534 million to $562 million, compared to prior guidance of $560 million to $591 million. release May 16, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $512 million to $538 million, compared to prior guidance of $534 million to $562 million. release Aug 15, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $515 million to $532 million, compared to prior guidance of $512 million to $538 million. release Nov 6, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Jan 3, 2026) |
Given $1.11 to $1.24 release Feb 7, 2025
Lowered $1.05 to $1.15 release May 16, 2025
Lowered $1.00 to $1.10 release Aug 15, 2025
Narrowed $1.02 to $1.08 release Nov 6, 2025
|
– | No standard number | |
The company's wordsFor the 53-week Fiscal 2025, the Company Expects: … Adjusted diluted EPS (3) in the range of approximately $1.11 to $1.24. release Feb 7, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted diluted EPS (2) of approximately $1.05 to $1.15, compared to prior guidance of $1.11 to $1.24. release May 16, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted diluted EPS (2) of approximately $1.00 to $1.10, compared to prior guidance of $1.05 to $1.15. release Aug 15, 2025 For the 53-week Fiscal 2025, the Company Expects: … Adjusted diluted EPS (2) of approximately $1.02 to $1.08, compared to prior guidance of $1.00 to $1.10. release Nov 6, 2025 | ||||
| Revenue Fiscal 2025 (ended Jan 3, 2026) |
Given $5.40B to $5.49B release Feb 7, 2025
Lowered $5.30B to $5.39B release May 16, 2025
Lowered $5.24B to $5.31B release Aug 15, 2025
Raised $5.25B to $5.31B release Nov 6, 2025
|
$5.26B 10-K filed 2026-02-25 |
Within the range | |
The company's wordsFor the 53-week Fiscal 2025, the Company Expects: … Net sales of approximately $5.403 billion to $5.487 billion, representing 5.9% to 7.5% growth compared to the prior year. release Feb 7, 2025 For the 53-week Fiscal 2025, the Company Expects: … Net sales of approximately $5.297 billion to $5.395 billion, representing 3.8% to 5.7% growth compared to the prior year. release May 16, 2025 For the 53-week Fiscal 2025, the Company Expects: … Net sales of approximately $5.239 billion to $5.308 billion, representing 2.7% to 4.0% growth compared to the prior year. release Aug 15, 2025 For the 53-week Fiscal 2025, the Company Expects: … Net sales of approximately $5.254 billion to $5.306 billion, representing 2.9% to 4.0% growth compared to the prior year. release Nov 6, 2025 | ||||
| Revenue (company-defined) Fiscal 2025 (ended Jan 3, 2026) |
Given $5.18B to $5.26B release Feb 7, 2025
Lowered $5.08B to $5.17B release May 16, 2025
Lowered $5.02B to $5.08B release Aug 15, 2025
Raised $5.03B to $5.08B release Nov 6, 2025
|
– | No standard number | |
The company's wordsFor the 53-week Fiscal 2025, the Company Expects: … Excluding the Simple Mills acquisition, we expect net sales of approximately $5.180 billion to $5.257 billion, representing 1.5% to 3.0% growth compared to the prior year. release Feb 7, 2025 For the 53-week Fiscal 2025, the Company Expects: … Excluding the Simple Mills acquisition, we expect net sales of approximately $5.079 billion to $5.170 billion, representing -0.5% to 1.3% growth compared to the prior year. release May 16, 2025 For the 53-week Fiscal 2025, the Company Expects: … Excluding the Simple Mills acquisition, we expect net sales of approximately $5.021 billion to $5.083 billion, representing a change of -1.6% to -0.4% compared to the prior year. release Aug 15, 2025 For the 53-week Fiscal 2025, the Company Expects: … Excluding the Simple Mills acquisition, we expect net sales of approximately $5.033 billion to $5.083 billion, representing a change of -1.4% to -0.4% compared to the prior year. release Nov 6, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 28, 2024) |
Given $524.00M to $553.00M release Feb 9, 2024
Kept $524.00M to $553.00M release May 16, 2024
Kept $524.00M to $553.00M release Aug 16, 2024
Lowered $530.00M to $542.00M release Nov 8, 2024
|
– | No standard number | |
The company's wordsFor the 52-week Fiscal 2024, the Company Expects: … Adjusted EBITDA (2) in the range of approximately $524 million to $553 million. release Feb 9, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted EBITDA (2) in the range of approximately $524 million to $553 million. release May 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted EBITDA (2) in the range of approximately $524 million to $553 million. release Aug 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted EBITDA (3) in the range of approximately $530 million to $542 million, compared to prior guidance of approximately $524 million to $553 million. release Nov 8, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 28, 2024) |
Given $1.20 to $1.30 release Feb 9, 2024
Kept $1.20 to $1.30 release May 16, 2024
Kept $1.20 to $1.30 release Aug 16, 2024
Raised $1.24 to $1.28 release Nov 8, 2024
|
– | No standard number | |
The company's wordsFor the 52-week Fiscal 2024, the Company Expects: … Adjusted diluted EPS (2) in the range of approximately $1.20 to $1.30. release Feb 9, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted diluted EPS (1) in the range of approximately $1.20 to $1.30. release May 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted diluted EPS (1) in the range of approximately $1.20 to $1.30. release Aug 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Adjusted diluted EPS (2) in the range of approximately $1.24 to $1.28, compared to prior guidance of approximately $1.20 to $1.30. release Nov 8, 2024 | ||||
| Revenue Fiscal 2024 (ended Dec 28, 2024) |
Given $5.09B to $5.17B release Feb 9, 2024
Kept $5.09B to $5.17B release May 16, 2024
Kept $5.09B to $5.17B release Aug 16, 2024
Narrowed $5.12B to $5.15B release Nov 8, 2024
|
$5.10B 10-K filed 2025-02-18 |
Below the range | |
The company's wordsFor the 52-week Fiscal 2024, the Company Expects: … Sales in the range of approximately $5.091 billion to $5.172 billion, representing 0.0% to 1.6% growth compared to the prior year. release Feb 9, 2024 For the 52-week Fiscal 2024, the Company Expects: … Sales in the range of approximately $5.091 billion to $5.172 billion, representing 0.0% to 1.6% growth compared to the prior year. release May 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Sales in the range of approximately $5.091 billion to $5.172 billion, representing 0.0% to 1.6% growth compared to the prior year. release Aug 16, 2024 For the 52-week Fiscal 2024, the Company Expects: … Net sales in the range of approximately $5.116 billion to $5.147 billion, representing 0.5% to 1.1% growth compared to the prior year. release Nov 8, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/FLO/export.csv") into a cell.